Ascend Wellness Holdings, Inc. (AAWH) — SEC Filings

Ascend Wellness Holdings, Inc. (AAWH) — 27 SEC filings. Latest: 10-Q (Nov 10, 2025). Includes 17 8-K, 4 10-Q, 2 DEF 14A.

View Ascend Wellness Holdings, Inc. on SEC EDGAR

Overview

Ascend Wellness Holdings, Inc. (AAWH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 10, 2025: Ascend Wellness Holdings, Inc. (AAWH) reported a net loss of $25.825 million for the three months ended September 30, 2025, a slight improvement from the $28.256 million net loss in the same period of 2024. For the nine months ended September 30, 2025, the net loss widened to $69.490 million from $6

Sentiment Summary

Across 27 filings, the sentiment breakdown is: 1 bearish, 26 neutral. The dominant filing sentiment for Ascend Wellness Holdings, Inc. is neutral.

Filing Type Overview

Ascend Wellness Holdings, Inc. (AAWH) has filed 4 10-Q, 17 8-K, 2 DEF 14A, 2 10-K, 1 SC 13G, 1 SC 13G/A with the SEC between Feb 2024 to Nov 2025.

Filings by Year

2025 · 2024

Recent SEC Filings (27)

Ascend Wellness Holdings, Inc. SEC Filing History
DateFormDescriptionRisk
Nov 10, 202510-QAscend Wellness Q3 Loss Narrows, Revenue Declines Amid Rising Debthigh
Aug 7, 20258-KAscend Wellness Holdings Files 8-K on Financialslow
May 28, 20258-KAscend Wellness Holdings Files 8-K on Financial Obligationsmedium
May 12, 20258-KAscend Wellness Holdings Files 8-K on Financialslow
May 2, 20258-KAscend Wellness Holdings Files 8-Klow
Mar 21, 2025DEF 14AAscend Wellness Holdings Files 2025 Proxy Statementlow
Mar 21, 20258-KAscend Wellness Appoints New Auditormedium
Mar 13, 202510-KAscend Wellness Holdings Files 2024 10-Kmedium
Mar 12, 20258-KAscend Wellness Holdings Files 8-K on Financialslow
Jan 14, 20258-KAscend Wellness Holdings Enters Material Definitive Agreementmedium
Dec 27, 20248-KAscend Wellness Holdings Files 8-Klow
Dec 17, 20248-KAscend Wellness Holdings Files 8-Klow
Nov 12, 202410-QAscend Wellness Holdings Files 2024 Q3 10-Qmedium
Aug 28, 20248-KAscend Wellness Holdings Appoints New Directors, CEO Gets New Contractmedium
Aug 7, 202410-QAscend Wellness Holdings Files Q2 2024 10-Qmedium
Aug 5, 20248-KAscend Wellness Holdings Files 8-Klow
Jul 22, 20248-KAscend Wellness Holdings Enters Material Definitive Agreementmedium
Jul 15, 20248-KAscend Wellness Holdings Files 8-Klow
May 31, 20248-KAscend Wellness Holdings Names New CFO, Elects Directorsmedium
May 8, 202410-QAscend Wellness Holdings, Inc. Files 10-Q for Q1 2024medium

Risk Profile

Risk Assessment: Of AAWH's 25 recent filings, 1 were flagged as high-risk, 12 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Ascend Wellness Holdings, Inc. Financial Summary (10-Q, Nov 10, 2025)
MetricValue
Revenue$124.734M
Net Income$(25.825M)
EPSN/A
Debt-to-Equity138.8
Cash Position$87.272M
Operating Margin-1.05%
Total Assets$900.362M
Total Debt$369.051M

Key Executives

  • Pamela G. Kenyon
  • David E. Johnson
  • Daniel Catalano
  • Daniel J. Curtin
  • Dr. Michelle L. Davis
  • Greg Boggs
  • Scott R. Runkle

Industry Context

Ascend Wellness Holdings operates within the dynamic and rapidly evolving cannabis industry. This sector is characterized by significant regulatory oversight at federal, state, and local levels, creating a complex operating environment. Competition is intensifying as more players enter the market, leading to potential pricing pressures and market share battles. Consumer demand is influenced by evolving social acceptance, economic conditions, and product innovation.

Top Tags

8-K (4) · 8-k (4) · Cannabis Industry (3) · financial-reporting (3) · financial-obligation (3) · filing (3) · financials (3) · 10-Q (3) · executive-compensation (3) · financial-condition (2)

Key Numbers

Ascend Wellness Holdings, Inc. Key Metrics
MetricValueContext
Revenue, net (Q3 2025)$124.734MDecreased from $141.647M in Q3 2024
Revenue, net (9 months ended Sep 30, 2025)$380.035MDecreased from $425.593M in the same period of 2024
Net loss (Q3 2025)$(25.825M)Improved from $(28.256M) in Q3 2024
Net loss (9 months ended Sep 30, 2025)$(69.490M)Worsened from $(68.203M) in the same period of 2024
Net cash provided by operating activities (9 months ended Sep 30, 2025)$21.737MDecreased from $38.126M in the same period of 2024
Long-term debt, net (Sep 30, 2025)$343.749MIncreased from $234.542M at Dec 31, 2024
Total stockholders' equity (Sep 30, 2025)$2.578MSignificantly decreased from $71.801M at Dec 31, 2024
Accumulated deficit (Sep 30, 2025)$(469.846M)Increased from $(400.356M) at Dec 31, 2024
Repurchase of common stock (9 months ended Sep 30, 2025)$1.580MContributed to decrease in stockholders' equity
Cash and cash equivalents (Sep 30, 2025)$87.272MSlightly decreased from $88.254M at Dec 31, 2024
SEC File Number333-254800Identifies the company's filings with the SEC.
IRS Employer Identification No.83-0602006Company's tax identification number.
Filing Date20250321The date the definitive proxy statement was filed with the SEC.
Meeting Date20250430The date of the shareholder meeting for which the proxy statement is issued.
Reporting Period2024 Q3Indicates the specific quarter for which financial data is reported.

Related Companies

AAWH.U · AWK

Frequently Asked Questions

What are the latest SEC filings for Ascend Wellness Holdings, Inc. (AAWH)?

Ascend Wellness Holdings, Inc. has 27 recent SEC filings from Feb 2024 to Nov 2025, including 17 8-K, 4 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of AAWH filings?

Across 27 filings, the sentiment breakdown is: 1 bearish, 26 neutral. The dominant sentiment is neutral.

Where can I find Ascend Wellness Holdings, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Ascend Wellness Holdings, Inc. (AAWH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Ascend Wellness Holdings, Inc.?

Key financial highlights from Ascend Wellness Holdings, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for AAWH?

The investment thesis for AAWH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Ascend Wellness Holdings, Inc.?

Key executives identified across Ascend Wellness Holdings, Inc.'s filings include Pamela G. Kenyon, David E. Johnson, Daniel Catalano, Daniel J. Curtin, Dr. Michelle L. Davis and 2 others.

What are the main risk factors for Ascend Wellness Holdings, Inc. stock?

Of AAWH's 25 assessed filings, 1 were flagged high-risk, 12 medium-risk, and 12 low-risk.

What are recent predictions and forward guidance from Ascend Wellness Holdings, Inc.?

Forward guidance and predictions for Ascend Wellness Holdings, Inc. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.